Cronos Group Inc.

CRON

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
CRON
CIK0001656472
SIC2833
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupMedicinal Chemicals

Contact

Address4491 CONCESSION RD 12, STAYNER, A6, L0M 1S0
Website thecronosgroup.com
Phone(416) 504-0004
CEOMichael R. Gorenstein
Employees450

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$130.28 million
Pre-Tax Income$18.82 million
Net Income$20.51 million
Net Income to Common$18.49 million
EPS$0.06
View All
Balance Sheet
Cash$794.42 million
Assets$1.18 billion
Liabilities$45.02 million
Common Equity$1.08 billion
Liabilities & Equity$1.18 billion
View All
Cash Flow Statement
Calculations
NOPAT$-59.28 million
EBITDA$-43.50 million
Price to Earnings$51.78
Price to Book$0.88
ROE1.88%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

How Is Altria Group's Stock Performance Compared to Other Consumer Defensive Stocks?

As Altria Group has performed weaker than its industry peers over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Article Link

Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint

We recently published 12 Best Healthcare Stocks to Buy Under $30. Cronos Group Inc. (NASDAQ:CRON) is one of the best healthcare stocks. Cronos Group Inc. (NASDAQ:CRON) is a global cannabis company operating primarily in Canada and Israel, with recognized brands like PEACE NATURALS and Spinach. The company focuses on both medicinal and recreational cannabis markets […]

Article Link

It’s 420 Somewhere: Aurora Cannabis Sparks Up the Top Line – Quarterly Update Report

Download the Complete Report Here By Rayk Riechmann Another impressive top-line beat by Aurora Cannabis Inc. (Nasdaq: ACB) should have investors fired up. The company reported a 17% revenue increase in its first fiscal quarter, mostly driven by a strong performance in the Global Medical Cannabis Market. ACB continues to outperform in key European markets […]

Article Link

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.

Article Link

Why Is Tilray (TLRY) Stock Soaring Today

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 38.5% in the afternoon session after reports that President Donald Trump is considering reclassifying marijuana as a less dangerous drug, a move that could transform the cannabis industry's regulatory landscape.

Article Link